These findings provide a justification for further studies on the prospect of BMP-7 as a therapeutic agent for treatment of kidney and lung cancers as well as the mechanism of inhibition of BMP-7 on these types of tumors. This evidence concerns the gene BMP7 and lung carcinoma.